Expansion and tumour specific cytokine secretion of bryostatin-activated T-cells from cryopreserved axillary lymph nodes of breast cancer patients

Medicine and Dentistry

• T Cell 100%
• Breast Cancer 100%
• Patient 100%
• Specific Tumor 100%
• Cytokine Release 100%
• Neoplasm 54%
• Cells 36%
• Culture 18%
• In Vitro 18%
• Adoptive Immunotherapy 18%
• Autologous Tumor Cell 18%
• Analysis 9%
• Malignant Neoplasm 9%
• Dissection 9%
• Low Drug Dose 9%
• Interferon 9%
• Stimulation 9%
• Cytokine 9%
• Lymphocyte 9%
• Interleukin 2 9%
• Lymph Node 9%
• Tumor Necrosis Factor 9%
• Ionomycin 9%
• Protein Kinase C Activator 9%
• Chromium Release Assay 9%
• Calcium Ionophore 9%
• Bryostatin 1 9%
• Cell Surface Marker 9%

Immunology and Microbiology

• Breast 100%
• Cytokine Release 100%
• Bryostatin 100%
• Cells 27%
• Cytokine 18%
• Tumor Cell 18%
• Adoptive Immunotherapy 18%
• Lysis 18%
• T Cell Activation 18%
• Mouse 9%
• CD4 9%
• Interferon Type I 9%
• Interleukin 2 9%
• Human Cell 9%
• CD8 9%
• Cell Count 9%
• Tumor Necrosis Factor Alpha 9%
• Low Drug Dose 9%
• Coculture 9%
• Cell Surface Marker 9%
• Bryostatin 1 9%

Biochemistry, Genetics and Molecular Biology

• Cytokine Release 100%
• Clinical Trial 18%
• Human Cell 18%
• Lysis 18%
• Mouse 9%
• Low Drug Dose 9%
• Calcium 9%
• Interferon 9%
• Protein Kinase C 9%
• CD4 9%
• CD8 9%
• Cell Activation 9%
• Interleukin 2 9%
• Tumor Necrosis Factors 9%
• Cell Count 9%
• Coculture 9%
• Cell Surface Marker 9%